Free Trial

Uniphar (LON:UPR) Hits New 12-Month High - Should You Buy?

Uniphar logo with Medical background

Uniphar plc (LON:UPR - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 328 ($4.45) and last traded at GBX 324 ($4.40), with a volume of 39492 shares trading hands. The stock had previously closed at GBX 321 ($4.36).

Wall Street Analyst Weigh In

Separately, Shore Capital reissued a "buy" rating on shares of Uniphar in a research note on Thursday, May 29th.

Get Our Latest Stock Report on UPR

Uniphar Price Performance

The stock has a market cap of £1.01 billion, a P/E ratio of 22.53 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The firm has a 50-day moving average price of GBX 271.11 and a 200-day moving average price of GBX 222.94.

Uniphar Company Profile

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Uniphar Right Now?

Before you consider Uniphar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.

While Uniphar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines